LianBio (LIANY)
OTCMKTS
· Delayed Price · Currency is USD
0.260
+0.003 (1.17%)
Dec 27, 2024, 4:00 PM EST
LianBio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 103.46 | 79.22 | 228.18 | 254.35 | 43.3 |
Short-Term Investments | 148.77 | 223.14 | 155.07 | - | - |
Cash & Short-Term Investments | 252.22 | 302.36 | 383.25 | 254.35 | 43.3 |
Cash Growth | -19.09% | -21.11% | 50.68% | 487.41% | - |
Other Receivables | 1.81 | 4.41 | 7.22 | 20.26 | - |
Receivables | 1.81 | 4.41 | 7.22 | 20.26 | - |
Prepaid Expenses | 1.91 | 4.04 | 7.68 | 0.1 | - |
Other Current Assets | 1.86 | 1.96 | 1.5 | 2.04 | 0.05 |
Total Current Assets | 257.81 | 312.77 | 399.65 | 276.75 | 43.35 |
Property, Plant & Equipment | 5.01 | 7.09 | 6.65 | 2.53 | 0.53 |
Other Long-Term Assets | 0.09 | 0.09 | 20.05 | 0.01 | - |
Total Assets | 262.9 | 319.96 | 426.34 | 279.29 | 43.88 |
Accounts Payable | 6.23 | 1.45 | 3.23 | 4.33 | - |
Accrued Expenses | 15.88 | 19.83 | 9.98 | 1 | 0.32 |
Current Portion of Leases | 1.89 | 1.85 | 1.13 | 0.54 | 0.18 |
Other Current Liabilities | 1.62 | 0.49 | 0.76 | 0.36 | 2.85 |
Total Current Liabilities | 25.63 | 23.62 | 15.09 | 6.23 | 3.35 |
Long-Term Leases | 0.95 | 2.49 | 3.71 | 1.34 | 0.35 |
Other Long-Term Liabilities | 0.21 | 0.21 | 20.21 | 20 | - |
Total Liabilities | 26.79 | 26.31 | 39.01 | 27.57 | 3.7 |
Common Stock | 0 | 0 | 0 | - | - |
Additional Paid-In Capital | 745.79 | 732.48 | 713.27 | 31.13 | 8.52 |
Retained Earnings | -540.23 | -470.53 | -360.24 | -163.94 | -24.33 |
Comprehensive Income & Other | -3.22 | -2.08 | 0.53 | -0.04 | - |
Total Common Equity | 202.34 | 259.87 | 353.56 | -132.84 | -15.82 |
Minority Interest | 33.77 | 33.77 | 33.77 | 34.77 | 1 |
Shareholders' Equity | 236.11 | 293.65 | 387.34 | 251.72 | 40.18 |
Total Liabilities & Equity | 262.9 | 319.96 | 426.34 | 279.29 | 43.88 |
Total Debt | 2.84 | 4.34 | 4.83 | 1.88 | 0.53 |
Net Cash (Debt) | 249.38 | 298.02 | 378.42 | 252.47 | 42.77 |
Net Cash Growth | -18.76% | -21.24% | 49.89% | 490.32% | - |
Net Cash Per Share | 2.32 | 2.76 | 11.00 | 20.95 | 8.78 |
Filing Date Shares Outstanding | 108.06 | 107.16 | 107.28 | 20.48 | 4.87 |
Total Common Shares Outstanding | 107.17 | 107.04 | 107.28 | 20.48 | 4.87 |
Working Capital | 232.18 | 289.16 | 384.56 | 270.52 | 40 |
Book Value Per Share | 1.89 | 2.43 | 3.30 | -6.49 | -3.25 |
Tangible Book Value | 202.34 | 259.87 | 353.56 | -132.84 | -15.82 |
Tangible Book Value Per Share | 1.89 | 2.43 | 3.30 | -6.49 | -3.25 |
Machinery | 1.54 | 1.22 | 0.54 | 0.19 | - |
Construction In Progress | 0.05 | 0.07 | 1.15 | 0.02 | - |
Leasehold Improvements | 3.2 | 3.37 | 0.81 | 0.69 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.